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ABSTRACT: Obstructive sleep apnoea syndrome (OSAS) might be a cause of heart failure. The
present study aimed to assess left ventricular mass and myocardial performance index (MPI) in
OSAS patients.
A total of 67 subjects without any cardiac or pulmonary disease, referred for evaluation of
OSAS, had overnight polysomnography and echocardiography. According to apnoea-hypopnoea
index (AHI), subjects were classified into three groups: mild OSAS (AHI: 5–14; n516), moderate
OSAS (AHI: 15-29; n518), and severe OSAS (AHI: o30; n533). Thickness of interventricular
septum (IVS) and posterior wall (LVPW) were measured by M-mode, along with left ventricular
mass (LVM) and LVM index (LVMI). Left ventricular MPI was calculated as (isovolumic contraction
time+isovolumic relaxation time)/aortic ejection time by Döppler echocardiography.
There were no differences in age or body mass index among the groups, but blood pressures
were higher in severe OSAS compared with moderate and mild OSAS. In severe OSAS, thickness
of IVS (11.2¡1.1 mm), LVPW (11.4¡0.9 mm), LVM (298.8¡83.1 g) and LVMI (144.7¡39.8 g?m-2)
were higher than in moderate OSAS (10.9¡1.3 mm; 10.8¡0.9 mm; 287.3¡74.6 g;
126.5¡41.2 g?m-2, respectively) and mild OSAS (9.9¡0.9 mm; 9.8¡0.8 mm; 225.6¡84.3 g;
100.5¡42.3 g?m-2, respectively). In severe OSAS, MPI (0.64¡0.14) was significantly higher than
in mild OSAS (0.50¡0.09), but not significantly higher than moderate OSAS (0.60¡0.10).
In conclusion, severe and moderate obstructive sleep apnoea syndrome patients had higher left
ventricular mass and left ventricular mass index, and also left ventricular global dysfunction.
KEYWORDS: Left ventricular mass, myocardial performance index, obstructive sleep apnoea
syndrome
O
bstructive sleep apnoea syndrome
(OSAS) is characterised by repetitive
collapse of the upper airway during
sleep [1]. The obstructive apnoeic event is
associated with considerable breathing efforts
against a totally or partially occluded upper
airway, and apnoea is terminated by an arousal
and heavy snoring as airflow is restored. Severity
of OSAS is described according to total number
of apnoeas and hypopnoeas per hour of sleep,
which is named as the apnoea-hypopnoea index
(AHI).
Cardiovascular disturbances are the most serious
complications of OSAS [2]. These complications
include heart failure [3], acute myocardial infarc-
tion [4], nocturnal arrhythmias [5], stroke [6],
systemic [7, 8] and pulmonary hypertension [9].
All these cardiovascular complications increase
morbidity and mortality of OSAS. Currently,
sleep apnoea is accepted as one of the identifiable
causes of hypertension [10]. Also, OSAS is closely
associated with obesity [11] and ageing [12].
OSAS contributes to the development of left
ventricular hypertrophy (LVH) [13]. The pro-
posed causes include associated changes in left
ventricular afterload, intermittent hypoxaemia,
and recurrent arousals during sleep. LVH is a
major independent risk factor for morbidity and
mortality from cardiovascular disease [14, 15, 16].
It was shown that many subjects with LVH have
normal blood pressure, suggesting that factors
other than haemodynamic overload may contri-
bute to the hypertrophy [17]. Diastolic dysfunc-
tion precedes left ventricular systolic impairment
and accounts for ,30–40% of patients with left
ventricular failure alone [18, 19]. Early recogni-
tion and appropriate therapy of left ventricular
diastolic dysfunction (LVDD) is advisable to
prevent further progression to heart failure and
death [18, 19]. Since systolic and diastolic
dysfunctions frequently coexist, it was shown
that a combined measure of left ventricular
performance might be more reflective of overall
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cardiac dysfunction than systolic or diastolic measures alone
[20, 21]. The left ventricular myocardial performance index
(MPI) reflects both systolic and diastolic left ventricular
functions (global functions). In the presence of global dysfunc-
tion of the left ventricle, MPI increases in contrast to ejection
fraction (EF) of the left ventricle. MPI is a reproducible, widely
applicable and a simple noninvasive method for the estimation
of left ventricular global function in the patients.
In the present study, the current authors aimed to estimate the
left ventricular mass (LVM) and global function in OSAS
patients, and evaluated the relationship between MPI and
AHI.
METHODS
Study population
To be eligible, all of the 92 subjects admitted to the sleep clinic
with symptoms of nocturnal snoring and/or excessive day-
time sleepiness had to fulfil the following criteria: absence of
1) any known cardiac and lung disease; 2) diabetes mellitus;
3) angina pectoris; 4) atrial fibrillation or any arrhythmias;
5) chronic renal and hepatic diseases; and 6) serum electrolytes
imbalances.
A total of 67 out of 92 subjects were admitted to the study. A
detailed sleep and cardiovascular history of the patients were
recorded. Sleep cycle, nutritional status, medications, alcohol
usage and family anamnesis were also questioned. Epworth
sleepiness scale (ESS) [22] was assessed in all patients, and
patients having high scores (ESS o10) were taken into the
sleep study.
Physical examination was performed in all subjects. Systolic
and diastolic blood pressures (SBP and DBP, respectively)
were measured consecutively in the sitting position on the
right arm using a sphygmomanometer (Erka, Bad Tölz,
Germany), after o5 min of rest. Hypertension was defined
as a blood pressure o140/90 mmHg or by the use of
antihypertensive drugs. However, all hypertensive patients
in the study group were taking antihypertensive medication.
Heart rate (HR) per minute was measured in the sitting
position, and body mass index (BMI) of the patients
were calculated as weight divided by height square (kg?m-2).
Pulmonary function tests (SensorMedics 2400; SensorMedics,
Bilthoven, The Netherlands), arterial blood gas analysis (ABL
30; Radiometer, Copenhagen, Denmark) were performed in all
patients at rest. A 12-lead surface ECG was taken from every
subject, and all of them were in sinus rhythm. All subjects also
underwent a treadmill exercise test and the test was normal for
each subject.
Polysomnography
Polysomnography was applied to all subjects on the night of
diagnosis [23]. The portable, limited sleep study performed
with the Embletta device (Flaga hf. Medical Devices,
Reykjavik, Iceland; distribution by ResMed) [24], consisted of
the following: 1) nasal pressure detector using nasal cannulae/
pressure transducer system, recording the square root of
pressure as an index of flow; 2) thoraco-abdominal movement
detection through two piezoelectric belts; 3) finger pulse
oximeter; and 4) body position detection.
Apnoea was defined as a total obstruction of oronasal airflow
for o10 s, hypopnoea was defined as a decrease of airflow of
o50%, and desaturations were accepted as a o4% decrease in
oxygen saturation [25]. Desaturation index (DI) was defined as
the number of oxygen desaturation events per hour of sleep.
Subjects with an AHI o5 were diagnosed as having OSAS [26].
Patients with OSAS were divided into three groups according
to AHI: mild OSAS (AHI: 5–14; n516), moderate OSAS (AHI:
15–29; n518), and severe OSAS (AHI: o30; n533).
Echocardiographic measurements
All measurements were performed with the subjects in the left
lateral decubitus position by M-mode, two dimensional, and
Döppler ultrasound echocardiography. The ultrasound equip-
ment used was Contron Sigma Iris (Contron Medical, Paris,
France) with a 2.5-MHz probe. The duration of the examina-
tion was o20 min. The ventricular diameters, volumes and
functions were measured according to the recommendations of
the American Society of Echocardiography [27]. Basic mea-
surements of left ventricular dimensions in diastole and
systole, thickness of interventricular septum (IVS), left ven-
tricular posterior wall (LVPW) and LVM were measured by
the M-mode technique and LVM was divided with body
surface area to obtain LVM index (LVMI). Left ventricular EF
by Simpson’s method was calculated as:
(diastolic volumesystolic volume)=diastolic volume ð1Þ
Early (E) and atrial (A) transmitral maximal flow velocities, the
ratio (E/A) and deceleration time of E-wave were registered.
Isovolumic relaxation time (IVRT) was measured by the
continuous wave Döppler technique. The velocity of mitral
flow propagation was estimated using colour Döppler M-
mode. The left ventricular MPI was calculated as:
(isovolumic contraction timezIVRT)=aortic ejection time ð2Þ
Statistical analysis
Data are presented as mean¡SD, and the Kruskal-Wallis test
was used for group comparisons. Mann-Whitney U-test was
used when only two groups were compared. A p-value ,0.05
was considered statistically significant.
RESULTS
A total of 56 males (83.6%) and 11 females (16.4%) were
included in the study. None were using alcohol, but 62% of
them were smoking cigarettes. The mean ESS score of the
study population was 17.2¡5.1 (range 10–23). Basic char-
acteristics of the patients with OSAS are shown in table 1.
There were no significant differences in their age, sex, BMI,
and HR among the OSAS patients (p.0.05). However, SBP
and DBP were higher in the severe OSAS patients than
moderate and mild OSAS patients. Of 67 OSAS patients, 38
were hypertensive, and the majority (68.4%) were in the
severe group. As usual, AHI and DI were the highest in
patients with severe OSAS (p,0.0001), and, in contrast, these
patients had both the lowest average and minimum nocturnal
saturation of arterial oxygen (Sa,O2) (p,0.0001). Percentage of
sleep duration at ,90% Sa,O2 was significantly higher in the
severe OSAS group, while it was the lowest in the mild OSAS
group.
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Basic echocardiographic measurements of the left ventricle in
patients with OSAS are shown in table 2. While left ventricular
end-diastolic and end-systolic diameters were not statistically
different among groups of OSAS patients, left atrial diameter
was significantly higher in severe OSAS patients compared
with mild OSAS patients (p,0.01). In severe OSAS patients,
thickness of IVS (11.2¡1.1 mm), LVPW (11.4¡0.9 mm), LVM
(298.8¡83.1 g) and LVMI (144.7¡39.8 g?m-2) were higher than
both moderate OSAS (10.9¡1.3 mm; 10.8¡0.9 mm; 287.3¡
74.6 g; 126.5¡41.2 g?m-2, respectively) and mild OSAS patients
(9.9¡0.9 mm; 9.8¡0.8 mm; 225.6¡84.3 g; 100.5¡42.3 g?m-2,
respectively). Basic measurements in the different OSAS
groups are shown in table 3.
The left ventricular systolic and diastolic functions in patients
with OSAS were shown in table 4. Left ventricular systolic
functions (EF and fractional shortening) were not significantly
different in three groups of OSAS patients, and were in normal
limits. While mild OSAS patients had normal left ventricular
diastolic functions, whereas moderate and severe OSAS
patients had LVDD. The left ventricular MPI was significantly
higher in severe OSAS patients (0.64¡0.14) than in mild OSAS
patients (0.50¡0.09; p,0.01). Also, MPI was statistically
different between moderate (0.60¡0.10) and mild OSAS
patients (0.50¡0.09; p,0.01), but it was not statistically
different between severe and moderate OSAS patients
(p.0.05).
A positive correlation was shown between left ventricular MPI
and AHI, reflecting severity of OSAS (p,0.001, r50.825).
Correlation between MPI and AHI in OSAS patients is shown
in figure 1. Cumulative time (h) with Sa,O2,90% of all OSAS
patients was calculated as 3.4¡1.2 h, and it was positively
correlated with left ventricular MPI (r50.847, p,0.001).
Correlation between cumulative time (h) with Sa,O2,90% and
left ventricular MPI is shown in figure 2.
TABLE 1 Basic characteristics of the patients with
obstructive sleep apnoea syndrome (OSAS)
Patients with OSAS
AHI 5–14 AHI 15–29 AHI o30 p-value
Subjects n 16 18 33
Mean age yrs 46.0¡5.6 46.5¡4.9 48.1¡6.5 NS
Male n (%) 13 (81.3) 15 (83.3) 28 (84.8) NS
Female n (%) 3 (18.7) 3 (16.7) 5 (15.2) NS
BMI kg?m-2 29.3¡2.4 30.4¡4.0 30.6¡3.7 NS
SBP mmHg 115.0¡24.5 122.2¡8.3 136.3¡15.7 0.001
DBP mmHg 77.5¡17.3 83.3¡5.0 89.7¡9.3 0.01
HR pulse?min-1 77.3¡9.1 76.1¡10.7 86.4¡13.4 NS
Hypertension n (%) 4 (25) 8 (44.4) 26 (61.9) 0.004
AHI per h 5.2¡2.8 25.3¡2.6 50.1¡11.6 0.0001
DI per h 9.2¡4.5 18.8¡12.1 37.8¡18.0 0.0001
Minimum Sa,O2 % 83.8¡5.7 78.2¡7.6 73.8¡18.9 0.0001
Average Sa,O2 % 94.1¡3.2 85.2¡5.9 80.3¡11.4 0.0001
Sleep duration %# 2.1 42.3 55.4 0.0001
Data are presented as n, n (%) or mean¡SD. AHI: apnoea-hypopnoea index;
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood
pressure; HR: heart rate; DI: desaturation index; Sa,O2: saturation of nocturnal
arterial oxygen; NS: nonsignificant. #: at Sa,O2,90%.
TABLE 3 Statistical comparison of the basic measurements
in the different obstructive sleep apnoea syndrome
groups#
Group 1
versus 2
Group 1
versus 3
Group 2
versus 3
SBP mmHg 0.04 0.001 0.001
DBP mmHg NS 0.008 0.01
Left atrium mm NS 0.01 NS
IVSD mm 0.01 0.001 NS
PLVWD mm 0.01 0.001 NS
LVM g 0.001 0.0001 NS
LVMI g?m-2 0.002 0.001 NS
IVRT ms 0.01 0.01 NS
E/A ratio 0.01 0.01 NS
MPI 0.01 0.01 NS
Data are presented as p-values obtained using the Mann-Whitney U-test. #:
group 1: apnoea-hypopnoea index (AHI)55–14, group 2: AHI515–29, and
group 3: AHI o30. SBP: systolic blood pressure; DBP: diastolic blood
pressure; IVSD: interventricular septum thickness in diastole; PLVWD: posterior
left ventricular wall thickness in diastole; LVM: left ventricular mass; LVMI: left
ventricular mass index; IVRT: isovolumic relaxation time; E/A: the ratio of early
transmitral/atrial transmitral maximal flow velocities; MPI: myocardial perform-
ance index; NS: nonsignificant.
TABLE 2 Basic echocardiographic measurements of the left
ventricle in patients with obstructive sleep apnoea
syndrome (OSAS)
Patients with OSAS
AHI 5–14 AHI 15–29 AHI o30 p-value
Subjects n 16 18 33
Thickness and
diameters mm
Left atrium# 19–40 32.8¡2.3 34.6¡6.4 36.1¡5.7 0.02
IVSD# 6–11 9.9¡0.9 10.9¡1.3 11.2¡1.1 0.001
PLVWD# 6–11 9.8¡0.8 10.8¡0.9 11.4¡0.9 0.001
LVEDD# 37–56 47.8¡6.6 49.5¡4.6 50.6¡5.6 NS
LVESD# 19–40 30.5¡5.6 32.1¡4.0 33.2¡4.8 NS
Left ventricular mass
LVM#," g 225.6¡84.3 287.3¡74.6 298.8¡83.1 0.0001
LVMI#,+ g?m-2 100.5¡42.3 126.5¡41.2 144.7¡39.8 0.004
Data are presented as mean¡SD or n. AHI: apnoea-hypopnoea index; IVSD:
interventricular septum thickness in diastole; PLVWD: posterior left ventricular
wall thickness in diastole; LVEDD: left ventricular end-diastolic diameter;
LVESD: left ventricular end-systolic diameter; LVM: left ventricular mass; LVMI:
left ventricular mass index. #: normal values; ": ,198 in females, ,294 in
males; +: ,110 in females, ,134 g?m-2 in males; NS: nonsignificant.
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DISCUSSION
Obstructive sleep apnoea syndrome might cause cardiovascu-
lar complications, such as heart failure, myocardial infarction
arryhthmias, systemic and pulmonary hypertension. Since the
left ventricular function was closely related to mortality and
morbidity, the current authors aimed to estimate the left
ventricular MPI reflecting ventricular global function in OSAS
patients.
Patients with OSAS often have coexisting disorders, which have
been associated with increased LVM and diastolic dysfunction,
such as obesity [28], hypertension [29] and diabetes mellitus
[30]. Arterial hypertension, evidence of LVH, high BMI, diabetes
mellitus and coronary artery disease are independent predictors
of diastolic dysfunction. In the current study, diabetes mellitus
and coronary artery disease were excluded, and there were no
significant differences in age and BMI of the patients. However,
38 out of 67 OSAS patients were hypertensive and majority of
them (68.4%) were in the severe group. It is well known that the
risk of developing systemic hypertension increases depending
on the severity of OSAS [31, 32]. HEDNER et al. [33] showed that
nocturnal hypoxemia increases sympathetic stimulation and
this might cause systemic hypertension. In patients in the
current study, percentage of sleep duration ,90% Sa,O2 was the
highest in the severe OSAS group, while it was lowest in the
mild OSAS group. Therefore, the severe OSAS patients had
more hypoxic duration in their sleep compared with moderate
and mild OSAS groups. However, ARABI et al. [34] have
previously proven that systemic hypertension develops in
hypoxic situations in normotensive cases, and, furthermore,
they showed a decrease in the adrenergic mediators in patients
having continuous positive airway pressure therapy for OSAS.
Currently, sleep apnoea is accepted as one of the identifiable
causes of hypertension in the Joint National Committee 7 report
[10].
In the current study, severe OSAS patients had slight LVH.
Moreover, IVS and LVPW diameters, and LVM and LVMI, were
slightly higher in patients with severe OSAS, while they were
within normal limits in patients with mild and moderate OSAS.
The current study does not explain the reason for LVH;
however, it could be caused by high blood pressures and/or
nocturnal hypoxemia. A multivariate analysis should have been
used in a large study population, in order to explain the effects
of blood pressures or hypoxemia on LVH. The small number of
patients in the present study population is an important
limitation when trying to determine that. HEDNER et al. [13]
reported that OSAS causes LVH in a study that compared
61 males with OSAS and 61 male control subjects. The OSAS
TABLE 4 Left ventricular functions by echocardiography in
patients with obstructive sleep apnoea syndrome
AHI 5–14 AHI 15–29 AHI o30 p-value
Subjects n 16 18 33
Parameters of
systolic function
EF 55–75%# 65.6¡4.2 64.4¡3.7 64.0¡4.9 NS
FS 28–41%# 36.2¡2.8 34.5¡2.8 34.9¡3.7 NS
Parameters of
diastolic function
E-velocity m?s-1 0.92¡0.12 0.77¡0.24 0.61¡0.13 0.01
A-velocity m?s-1 0.67¡0.25 1.05¡0.9 0.87¡0.14 0.01
E/A ratio .1# 1.37¡0.02 0.73¡0.01 0,70¡0.01 0.01
DT ,220# m?s-1 170.1¡20.9 210.0¡47.7 240.1¡57.7 0.01
IVRT ,100# m?s-1 72.0¡12.6 100.2¡13.7 125.5¡13.1 0.01
VPR .55# cm?s-1 95.2¡10.1 59.2¡18.1 36.0¡7.0 0.01
Global function
MPI 0.39¡0.05# 0.50¡0.09 0.60¡0.10 0.64¡0.14 0.01
Data presented as mean¡SD. AHI: apnoea-hypopnoea index; EF: left
ventricular ejection fraction in two dimensions by Simpson’s method; FS:
fractional shortening; E-velocity: early mitral flow velocity; A-velocity: atrial mitral
flow velocity; E/A: ratio of early and atrial mitral flow velocity; DT: mitral
deceleration time; IVRT: isovolumic relaxation time; VPR: velocity of mitral flow
propagation; MPI: myocardial performance index; NS: not significant. #: normal
values.
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FIGURE 1. Correlation between myocardial performance index (MPI) and
apnoea-hypopnoea index (AHI) in obstructive sleep apnoea patients (r50.83;
p,0.001).
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FIGURE 2. Correlation between cumulative time (h) with saturation of nocturnal
arterial oxygen (Sa,O2) at ,90% and ventricular myocardial performance index (MPI).
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group were heavier and 50% had systemic hypertension. They
reported that LVM was ,15% higher among normotensive
OSAS patients compared with normotensive control subjects,
despite comparison of subjects with matching BMI. More
recently, NODA et al. [35] reported echocardiographic evidence
of LVH in 50% of patients with an AHI .20?h-1 compared with
21.4% in those with an AHI ,20?h-1. In contrast, DAVIES et al. [36]
did not find a significant difference in LVM, determined by
echocardiography, between 19 patients with OSAS, 19
nonapnoeic snorers, and 38 control subjects matched for age,
sex and BMI.
The proposed causes of LVH in OSAS include associated
changes in left ventricular afterload, intermittent hypoxemia,
and recurrent arousals during sleep. Left ventricular afterload
increases during sleep in patients with OSAS because of the
combined effects of increased negative intrathoracic pressure,
associated with attempted breathing against an occluded
upper airway [37], and increased systemic blood pressure
[33] associated with elevated sympathetic nervous system
activity, hypoxemia, and arousal from sleep [38]. Forced
inspiration against increased airway resistance during wake-
fulness (Mueller manoeuvre) raises aortic transmural pressure,
thereby increasing aortic stiffness and left ventricular systolic
load [39]. Isovolumic relaxation time of the left ventricle has
also been shown to increase in the presence of either
hypertension-related or age-dependent increase in aortic
stiffness [40].
The current study showed that moderate and severe OSAS
patients had LVDD and, also, had global dysfunction
diagnosed with increased MPI, although they had normal left
ventricular EFs. Since the systolic and diastolic dysfunction
frequently coexist, it was shown that a combined measure of
left ventricular performance with calculation of MPI might be
more reflective of overall cardiac dysfunction than systolic or
diastolic measures alone. Diastolic dysfunction can be found in
25% of asymptomatic hypertensives without LVH, but in 90%
of those having LVH [19]. Reduced early diastolic filling in
hypertensive patients has generally been correlated with
increased afterload and increased muscle mass. Additionally,
hypertension is associated with left atrial enlargement and
depression of atrial contractile function. Several mechanisms
can impair diastolic function in hypertension [41]. The
predominant role of hypertension for the development of
diastolic heart failure was initially established by the
Framingham Heart Study [42]. Diastolic dysfunction in
hypertensive patients can occur even in the absence of
structural myocardial abnormalities and usually represents
myocyte dysfunction with impaired isovolumic relaxation.
Also, the current authors cannot explain exactly the reason of
diastolic dysfunction; it could be caused by high blood
pressures and/or nocturnal hypoxemia. Left ventricular
diastolic filling is a complex event that is influenced by several
factors, such as left ventricular relaxation, left ventricular
compliance, left atrium contraction force, HR and systemic
vascular resistance. Thus, left ventricular dysfunction might be
the result of a variety of impairments.
Study limitations
The small number of patients in the current study population
is an important study limitation for determining the effects of
blood pressures or nocturnal hypoxemia on LVH and diastolic
dysfunction. Also, the sleep clinic population may not reflect
the findings in the general community.
Conclusions
The present study demonstrates that increased apnoea-
hypopnoea index in patients with obstructive sleep apnoea
syndrome may result in left ventricular dysfunction. In
this study, a significant positive correlation was shown
between myocardial performance index and severity of
obstructive sleep apnoea syndrome. Since diastolic dysfunc-
tion might be combined with systolic dysfunction, severe
obstructive sleep apnoea syndrome patients having diastolic
dysfunction might have an increased risk of heart failure.
Myocardial performance index is a reproducible, widely
applicable and simple noninvasive method for the estimation
of left ventricular global function in patients with obstructive
sleep apnoea syndrome. It will be important to resolve whether
left ventricular dysfunction may be corrected by continuous
positive airway pressure treatment aimed at reducing
upper airway obstruction in the patients with obstructive
sleep apnoea syndrome. Since the ventricular functions
provide prognostic information in patients, the results from
this study should be further confirmed with several longi-
tudinal studies.
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